Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People who have had an ischemic stroke (a stroke caused by a blocked blood vessel) confirmed by an MRI scan
- People whose stroke involves a blockage in a specific large artery in the brain (known as the M1 and/or M2 segments)
- People for whom doctors have determined are eligible for clot-dissolving medication and/or a procedure to physically remove the clot
- People who have signed a consent form, or whose next of kin has signed on their behalf
- People who have a French social security number
For the optional sub-study (ancillary study), additional criteria apply:
- People already enrolled in the Hibiscus Stroke II patient group
- People (or their next of kin) who have signed a separate consent form for the sub-study
Who may not be able to join:
- People who are unlikely to be able to attend a follow-up appointment at Pierre Wertheimer Hospital in Lyon, France, three months after joining
- People who have cancer that is actively spreading or not under control
- People who have had their civil rights removed (confirm with trial site)
- Women who are pregnant, or women who could become pregnant and cannot provide proof that they are not currently pregnant
- For the optional stool sample part of the study: people who have taken antibiotics in the past 3 months, used probiotic or gut health supplements in the past 3 months, have had certain bowel or stomach surgeries, have Crohn's disease or a chronic inflammatory bowel condition, have had a specific stomach ulcer caused by a bacteria called Helicobacter pylori within the past year, or are taking part in another study that aims to change gut bacteria
For the optional sub-study (ancillary study), additional criteria apply:
- People for whom an MRI scan using a contrast dye called gadolinium is not safe
- People for whom a heart MRI scan is not safe or is not possible
- People whose kidneys are not filtering blood well enough (a specific kidney function measurement below 30ml/min)
- People who have a history of coronary artery disease (blocked or narrowed arteries supplying the heart)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33 4 72 35 71 70
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Specific primary endpoint will be established for each sub-study based on data from the HIBISCUS-Stroke II cohort such as the Rankin score at 3 months.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.